Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, August 26 2016 5:35am ET - U.S. Markets open in 3 hours and 55 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Biotechnology News
Latest News
Friday, Aug 26, 2016
·Hemispherx Biopharma Announces Major Breakthrough: Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic
GlobeNewswire - 1 hour, 5 minutes ago
·Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
PR Newswire - 2 hours, 49 minutes ago
·Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.
CNW Group - 2 hours, 49 minutes ago
·IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Juno Therapeutics Inc. and Reminds Investors with Losses In Excess of $50,000 to Contact the Firm
- Thu 5:22 pm ET
·PharmAthene Withdraws Protest Against HHS Over Anthrax Vaccine Bidding Process
PR Newswire - Thu 5:00 pm ET
Thursday, Aug 25, 2016
·An In-Depth Look at the VBI Vaccines CMV Study
- Thu 4:58 pm ET
·uniQure Announces Financial Results For Second Quarter 2016 and Update on Company Progress
GlobeNewswire - Thu 4:18 pm ET
·Cempra’s Pivotal Phase 3 SOLITAIRE-IV Study of IV to Oral Solithromycin Published in Clinical Infectious Diseases
GlobeNewswire - Thu 4:05 pm ET
·Anika to Participate in Upcoming Investor Conferences
Business Wire - Thu 4:05 pm ET
·Janney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy Franchise'
- Thu 3:52 pm ET
·ADXS: Multiple Progresses Have Been Made
- Thu 3:30 pm ET
·GenVec faces delisting threat after it fails to raise share price
at - Thu 3:00 pm ET
·BCLI: Planning for Phase 3 Study of NurOwn™ in ALS Following Successful Phase 2 Results
- Thu 3:00 pm ET
·Vanda Patents Found Valid and Infringed in Fanapt® ANDA Litigation
PR Newswire - Thu 2:51 pm ET
·SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. for $81.50 Per Share is Fair to Shareholders
Business Wire - Thu 2:50 pm ET
·Vanda Pharmaceuticals: 'A Major Upside Surprise'
at - Thu 2:38 pm ET
·Vanda Pharmaceuticals (VNDA) Stock Soars on Drug Patent Ruling
at - Thu 1:44 pm ET
·JUNO INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Securities Class Action Against Juno Therapeutics, Inc.
Business Wire - Thu 1:10 pm ET
·What’s BioMarin’s Expected Revenue Growth in 2016 and 2017?
- Thu 1:04 pm ET
·Clovis boosted by FDA acceptance of cancer drug
at - Thu 12:15 pm ET
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?